Skip to main content
. 2017 Dec 8;23(3):316–323. doi: 10.1634/theoncologist.2017-0544

Figure 2.

image

Treatment with brentuximab vedotin induced a complete response in a patient (Case 4) with a germ cell tumor. Computed tomography scans over time of a right lung nodule (A), second right lung nodule (B), and mediastinal lymph node (C) in the patient in Case 4 who was treated with 1.8 mg/kg brentuximab vedotin. After cycle 2, the patient achieved a partial response that converted into a durable complete response after cycle 4.